With over three decades of work experience, Scott Rocklage proved to be an excellent venture partner when he joined 5 AM Ventures. Starting out in the company in 2003. Scott quickly rose up the ranks and rose to the position of Managing Partner just a year later.
5 AM Ventures is a company that aims to revolutionize scientific studies and research by investing in businesses that are actively working towards developing life sciences. The company seeks to give the necessary backing which a company would need to get off the ground and establish themselves. The primary objective of the company is to help with the progress of the healthcare industry by providing companies with the monetary backing they would need. 5 AM Ventures invests in a range of sectors, right from biopharmaceuticals to research and medical technology implementation. In addition to investing into the company’s, 5 AM Ventures also help companies with the necessary guidance to ensure the success of their business.
Scott is driven by the old fashioned ways of investing and helping companies. He believes in forming close ties with his clients and paying close attention to them, to give them all that they would need to start their business. Because of the extensive knowledge that Scott has on the matter of life sciences and healthcare, he can lead companies in a direction that is beneficial to their growth.
5 AM Ventures functions as a collaborative effort between four venture capitalist, John Diekman, Andy Schwab, Carin Mueller and of course Scott Rocklage. Scott has known his partners for over fifteen years and has been working closely alongside them for en extremely long time. The union of such learned and experienced investors is what has made 5 AM Ventures such a huge success.
Scott’s efforts at 5 AM Ventures have resulted in the company landing a host of big clients. During his first year at 5 AM Ventures, Scott landed companies like Alexa, Ambrx and Chelsea Therapeutics to name a few. Most of the businesses that Scott has made investments into have grown to be leaders in their field. Scotts determination to help the company succeed show in the broad portfolio of companies he has invested into.
In the past, Scott has tremendous experience in the field of medical advances and management. He previously worked with the FDA and helped in the formulation of new policies under the umbrella of the FDA. Scott also worked at Cubist Pharmaceuticals, where he headed the company as the CEO.
Scott Rocklage pursued his Bachelors in Chemistry from the University of California at Berkeley. He has also attained his Ph. D from MIT in Chemistry. Currently, Scott owns over 30 patents of various medical technologies in the United States. He has also had numerous publications regarding chemistry and life sciences.